K

A

KADI , Amir

Last name: KADI

First name: Amir

January 1, 2021 (v1)

Journal article

Metadata-only

Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer

Bidard, François-Clément Jacot, William Kiavue, Nicolas

Importance: The choice between chemotherapy and endocrine therapy as first-line treatment for hormone receptor-positive, ERBB2 (also known as HER2)-negative metastatic breast cancer is usually based on the presence of clinical features associated with a poor prognosis. In this setting, a high circulating tumor cell (CTC) count (≥5 CTCs/7.5 mL)...

Uploaded on: December 3, 2022